Press Enter to search · Esc to close
A new mechanistic review argues that after 50, the cardiovascular system and the skeletal muscle system age as one. Protecting muscle, in other words, may be vascular medicine in disguise.
A 1,416-patient analysis suggests a curated senescence gene signature tracks with survival in multiple myeloma — an early but credible sign that geroscience biomarkers may sharpen oncology prognosis.
A new study suggests sulforaphane sharpens the body's response to exercise in older adults, while a quarter-century of curcumin research keeps circling the same translational wall: bioavailability.
The Dog Aging Project's Precision Cohort turns 1,000 family pets into a living laboratory for geroscience — and a useful mirror for the rest of us.
Researchers have released a multi-tissue genomic dataset from the only long-term randomized trial of caloric restriction in healthy adults. It won't tell you what to eat tomorrow — but it may finally show how eating less rewires the biology of getting older.
A new European synthesis maps the levers — personal, clinical, and environmental — that may compress the years we spend sick at the end of a longer life.
A new wave of reviews argues that aging biology — not individual diseases — is medicine's highest-leverage target. Heart failure may be the proving ground.
Aging research is consolidating. A new wave of papers reframes the field around drug-targetable biology — and it could change what 'anti-aging' actually means.
A careful re-analysis of the Women's Health Initiative finds metformin initiators outlived sulfonylurea initiators on the way to age 90. It sharpens the longevity debate without ending it.